Guizhou Sanli Pharmaceutical Co.,Ltd (SHSE: 603439)
Health Care · Pharmaceuticals · CN
CN¥12.41
-8.28% today · -5.3% 1Y
Guizhou Sanli Pharmaceutical Co.,Ltd (SHSE: 603439) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $747.18M and employs 1,887 people.
Over the last twelve months the share price has lost 5.3%, trading between 9.51 and 17.46.
Tweenvest scores Guizhou Sanli Pharmaceutical Co.,Ltd across four factors: quality 71/100, value 43/100, growth 65/100, dividend 63/100. Its strongest factor is quality.
603439 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $747.18M
- Revenue (TTM)
- $242.99M
- P/E
- 106.11
- EPS
- 0.12
- Dividend yield
- 0.48%
- Beta (5Y)
- 0.97
- 52-week high
- CN¥17.46
- 52-week low
- CN¥9.51
- Avg volume (3M)
- —
- Shares outstanding
- 404.74M
- Employees
- 1,887
- Next earnings
- —
About Guizhou Sanli Pharmaceutical Co.,Ltd
This pharmaceutical enterprise is dedicated to the comprehensive process of developing, manufacturing, and distributing medicinal products. Its diverse portfolio includes therapeutic solutions for children, respiratory ailments, cardiovascular and cerebrovascular disorders, digestive issues, trauma recovery, rehabilitation needs, and ophthalmic conditions. The company commenced operations in 1995 and maintains its primary base in Guiyang, China.
- ISIN
- CNE1000040B4
- Founded
- 1995
- Listed since
- Apr 28, 2020
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,235.35 | +0.14% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.38 | +0.09% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.17 | -0.18% |
| Roche Holding AGSWX: ROP | $371.62B | CHF374.20 | +0.11% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.68 | -0.87% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.51 | -0.21% |
Figures last refreshed Aug 18, 2026.